Translational Approach for Predicting Human Pharmacokinetics of Engineered Therapeutic Monoclonal Antibodies with Increased FcRn-Binding Mutations

被引：0
|
作者：
Kenta Haraya
Tatsuhiko Tachibana
机构：
[1] Chugai Pharmaceutical Co.,
[2] Ltd.,undefined
来源：
BioDrugs | 2023年 / 37卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：99 / 108
页数：9
相关论文
共 25 条
  • [1] Translational Approach for Predicting Human Pharmacokinetics of Engineered Therapeutic Monoclonal Antibodies with Increased FcRn-Binding Mutations
    Haraya, Kenta
    Tachibana, Tatsuhiko
    BIODRUGS, 2023, 37 (01) : 99 - 108
  • [2] Prediction of human pharmacokinetics of Fc-engineered therapeutic monoclonal antibodies using human FcRn transgenic mice
    Haraya, Kenta
    Ichikawa, Takuya
    Murao, Naoaki
    Katada, Hitoshi
    Kuramochi, Taichi
    MABS, 2025, 17 (01)
  • [3] IgG1 Allotypes Influence the Pharmacokinetics of Therapeutic Monoclonal Antibodies through FcRn Binding
    Ternant, David
    Arnoult, Christophe
    Pugniere, Martine
    Dhommee, Christine
    Drocourt, Daniel
    Perouzel, Eric
    Passot, Christophe
    Baroukh, Nadine
    Mulleman, Denis
    Tiraby, Gerard
    Watier, Herve
    Paintaud, Gilles
    Gouilleux-Gruart, Valerie
    JOURNAL OF IMMUNOLOGY, 2016, 196 (02): : 607 - 613
  • [4] The influence of antibody engineering on Fc conformation and Fc receptor binding properties: Analysis of FcRn-binding engineered antibodies and an Fc fusion protein
    Suzuki, Takuo
    Hashii, Noritaka
    Tada, Minoru
    Ishii-Watabe, Akiko
    MABS, 2021, 13 (01)
  • [5] Comparison of Different Methods for Predicting Pharmacokinetics of Monoclonal Antibodies in Human
    Singh , Renu
    Moreno, Maria
    Stanimirovic, Danica
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2015, 42 : S36 - S37
  • [6] Pharmacokinetics of novel Fc-engineered monoclonal and multispecific antibodies in cynomolgus monkeys and humanized FcRn transgenic mouse models
    Valente, Delphine
    Mauriac, Christine
    Schmidt, Thorsten
    Focken, Ingo
    Beninga, Jochen
    Mackness, Brian
    Qiu, Huawei
    Vicat, Pascale
    Kandira, Abdullah
    Radosevic, Katarina
    Rao, Srini
    Darbyshire, John
    Kabiri, Mostafa
    MABS, 2020, 12 (01)
  • [7] Utility of a human FcRn transgenic mouse model in drug discovery for early assessment and prediction of human pharmacokinetics of monoclonal antibodies
    Avery, Lindsay B.
    Wang, Mengmeng
    Kavosi, Mania S.
    Joyce, Alison
    Kurz, Jeffrey C.
    Fan, Yao-Yun
    Dowty, Martin E.
    Zhang, Minlei
    Zhang, Yiqun
    Cheng, Aili
    Hua, Fei
    Jones, Hannah M.
    Neubert, Hendrik
    Polzer, Robert J.
    O'Hara, Denise M.
    MABS, 2016, 8 (06) : 1064 - 1078
  • [8] FcRn Affinity-Pharmacokinetic Relationship of Five Human IgG4 Antibodies Engineered for Improved In Vitro FcRn Binding Properties in Cynomolgus Monkeys
    Datta-Mannan, Amita
    Chow, Chi-Kin
    Dickinson, Craig
    Driver, David
    Lu, Jirong
    Witcher, Derrick R.
    Wroblewski, Victor J.
    DRUG METABOLISM AND DISPOSITION, 2012, 40 (08) : 1545 - 1555
  • [9] Prediction of Human Pharmacokinetics of Therapeutic Monoclonal Antibodies from Simple Allometry of Monkey Data
    Oitate, Masataka
    Masubuchi, Noriko
    Ito, Takashi
    Yabe, Yoshiyuki
    Karibe, Tsuyoshi
    Aoki, Takanori
    Murayama, Nobuyuki
    Kurihara, Atsushi
    Okudaira, Noriko
    Izumi, Takashi
    DRUG METABOLISM AND PHARMACOKINETICS, 2011, 26 (04) : 423 - 430
  • [10] Simple Approach to Accurately Predict Pharmacokinetics of Therapeutic Monoclonal Antibodies after Subcutaneous Injection in Humans
    Haraya, Kenta
    Tachibana, Tatsuhiko
    CLINICAL PHARMACOKINETICS, 2021, 60 (01) : 111 - 120
123